Fujifilm Holdings Corp

Chart & Performance

D1W1MN

P/E

13.79

P/S

1.13

EPS

202.11

Div Yield, %

1.43%

Shrs. gr., 5y

23.23%

Rev. gr., 5y

4.02%

Revenues

2.96t

+3.56%

Net income

243.51b

+10.98%

CFO

407.94b

+93.84%

Dividend

Mar 28, 20250 JPY/sh

Earnings

May 07, 2025

Profile

FUJIFILM Holdings Corporation develops, manufactures, sells, and services imaging, healthcare, materials, and business innovation solutions worldwide. The company's Healthcare segment provides products and services, such as medical devices, biomedical contract development and manufacturing organization, pharmaceutical, regenerative medicine, and cosmetics and supplements in the three areas of prevention, diagnosis, and treatment. Its Materials segment offers inkjet digital presses and printing plates for printing industries, as well as industrial inkjet-related products and inkjet heads; storage media and archiving services to save and manage digital data volumes; and materials for industrials, including display and touch panel, semiconductor and image sensor, and functional film materials. The company's Business Innovation segment provides devices and services used in offices, including digital multifunction devices, printers, software, and cloud services; workflow solutions for printing companies and others in the graphical communications sector; and document services tailored to diverse business formats and roles, including system integration, business process outsourcing, and others. Its Imaging segment offers color films, instant cameras, developing and printing systems, color papers, and photo printing services; and TV and cinema lenses, surveillance cameras, industrial lenses for production line inspection, and projectors. FUJIFILM Holdings Corporation was incorporated in 1934 and is headquartered in Tokyo, Japan.

URL

https://holdings.fujifilm.com/

IPO date

May 16, 1949

Employees

73,878

Domiciled in

Incorporated in

Valuation

Order:

Title JPY in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title JPY in thousands, except ratios and share amounts	2024‑03	2023‑03	2022‑03	2021‑03	2020‑03	2019‑03	2018‑03	2017‑03	2016‑03
Income
Revenues	2,960,916,000 3.56%	2,859,041,000 13.19%
Cost of revenue	2,684,191,000	2,585,962,000
Unusual Expense (Income)
NOPBT	276,725,000	273,079,000
NOPBT Margin	9.35%	9.55%
Operating Taxes	78,102,000	65,206,000
Tax Rate	28.22%	23.88%
NOPAT	198,623,000	207,873,000
Net income	243,509,000 10.98%	219,422,000 3.90%
Dividends	(56,170,000)	(46,109,000)
Dividend yield	1.38%	1.72%
Proceeds from repurchase of equity	(31,000)	(20,000)
BB yield	0.00%	0.00%
Debt
Debt current	349,692,000	211,440,000
Long-term debt	362,751,000	411,891,000
Deferred revenue		21,909,000
Other long-term liabilities	186,365,000	108,760,000
Net debt	132,690,000	163,467,000
Cash flow
Cash from operating activities	407,941,000	210,452,000
CAPEX	(417,966,000)	(323,472,000)
Cash from investing activities	(527,416,000)	(323,225,000)
Cash from financing activities	(462,000)	(123,695,000)
FCF	(416,722,000)	64,585,000
Balance
Cash	179,715,000	268,608,000
Long term investments	400,038,000	191,256,000
Excess cash	431,707,200	316,911,950
Stockholders' equity	2,785,847,000	2,845,089,000
Invested Capital	3,535,603,800	2,815,344,050
ROIC	6.25%	7.37%
ROCE	6.98%	8.58%
EV
Common stock shares outstanding	1,204,318	1,204,088
Price	3,370.00 50.94%	2,232.66 -10.72%
Market cap	4,058,550,491 50.97%	2,688,319,373 167.88%
EV	4,195,308,491	2,876,501,373
EBITDA	426,739,000	415,294,000
EV/EBITDA	9.83	6.93
Interest	8,483,000	5,006,000
Interest/NOPBT	3.07%	1.83%